Header Logo

Sonal Singh

Concepts (655)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Pulmonary Disease, Chronic Obstructive
15
2014
271
4.070
Why?
Hypoglycemic Agents
15
2021
199
4.030
Why?
Cough
13
2021
165
3.680
Why?
Diabetes Mellitus, Type 2
19
2018
646
3.670
Why?
Thiazolidinediones
10
2015
49
3.200
Why?
Cardiovascular Diseases
15
2017
692
2.900
Why?
Scopolamine Derivatives
9
2014
10
2.730
Why?
Drug-Related Side Effects and Adverse Reactions
6
2024
140
2.560
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
8
2019
186
2.290
Why?
Warfare
12
2014
30
2.270
Why?
Humans
179
2024
51356
2.220
Why?
Gastrointestinal Hemorrhage
5
2020
78
2.200
Why?
Randomized Controlled Trials as Topic
25
2024
507
2.190
Why?
Cholinergic Antagonists
6
2014
25
2.120
Why?
Pancreatitis
7
2015
89
2.050
Why?
Drugs, Generic
3
2018
17
1.900
Why?
Alzheimer Disease
3
2024
430
1.810
Why?
Decision Support Techniques
5
2020
154
1.570
Why?
Dabigatran
5
2023
22
1.560
Why?
Adverse Drug Reaction Reporting Systems
4
2017
45
1.530
Why?
Delivery of Health Care
7
2021
381
1.520
Why?
Adrenal Cortex Hormones
5
2018
110
1.440
Why?
Anticoagulants
10
2023
426
1.410
Why?
Pneumonia
6
2018
249
1.390
Why?
Research Design
11
2023
538
1.270
Why?
Benzazepines
3
2012
22
1.260
Why?
Myocardial Infarction
9
2018
788
1.230
Why?
Quinoxalines
3
2012
34
1.230
Why?
Bronchodilator Agents
4
2014
50
1.220
Why?
Myocardial Ischemia
3
2014
89
1.210
Why?
United States Food and Drug Administration
5
2018
86
1.210
Why?
Aortic Aneurysm
2
2018
74
1.200
Why?
Clinical Trials as Topic
9
2018
363
1.200
Why?
Administration, Inhalation
12
2014
81
1.160
Why?
Atrial Fibrillation
6
2023
582
1.160
Why?
Evidence-Based Medicine
8
2019
371
1.140
Why?
Risk Assessment
19
2020
1595
1.080
Why?
Warfarin
6
2015
95
1.070
Why?
Male
51
2023
23406
1.030
Why?
Aged
35
2024
11094
1.030
Why?
Renal Insufficiency
2
2023
50
1.020
Why?
Glucagon-Like Peptide 1
3
2018
16
0.990
Why?
Anti-Bacterial Agents
4
2018
589
0.970
Why?
Female
57
2022
26766
0.970
Why?
Algorithms
5
2020
896
0.970
Why?
Ipratropium
3
2014
7
0.950
Why?
Human Rights
5
2008
16
0.950
Why?
Asthma
2
2022
378
0.940
Why?
Nicotinic Agonists
3
2012
39
0.930
Why?
Primary Prevention
3
2019
111
0.910
Why?
Heart Failure
7
2016
663
0.890
Why?
Periodicals as Topic
2
2020
160
0.880
Why?
Anti-Asthmatic Agents
1
2022
38
0.870
Why?
Renal Insufficiency, Chronic
1
2023
85
0.860
Why?
Death, Sudden, Cardiac
2
2019
53
0.850
Why?
Prescription Drugs
3
2018
50
0.850
Why?
Review Literature as Topic
5
2016
36
0.820
Why?
Adult
33
2023
13456
0.820
Why?
Biological Products
1
2022
72
0.810
Why?
Antiparkinson Agents
1
2021
6
0.800
Why?
Dopamine Antagonists
1
2021
14
0.790
Why?
Fluoroquinolones
2
2018
21
0.790
Why?
HIV Infections
9
2017
822
0.780
Why?
Practice Guidelines as Topic
6
2018
592
0.750
Why?
Public Health
3
2007
156
0.750
Why?
Treatment Outcome
17
2023
4035
0.750
Why?
Middle Aged
35
2021
13569
0.750
Why?
Hospitalization
5
2022
1122
0.750
Why?
Nepal
13
2016
91
0.750
Why?
Tiotropium Bromide
8
2014
9
0.740
Why?
Risk Factors
20
2018
4329
0.740
Why?
Intracranial Hemorrhages
1
2020
41
0.730
Why?
Vaccination Coverage
1
2019
6
0.730
Why?
Pharmaceutical Preparations
1
2021
116
0.730
Why?
Wernicke Encephalopathy
4
2007
4
0.720
Why?
Testosterone
2
2016
124
0.710
Why?
Drug Prescriptions
1
2021
180
0.700
Why?
Myocarditis
1
2019
26
0.690
Why?
Glucocorticoids
2
2011
132
0.690
Why?
Stroke
6
2023
928
0.680
Why?
Human Rights Abuses
3
2007
3
0.680
Why?
Cardiovascular System
1
2019
35
0.680
Why?
Urinary Bladder Neoplasms
2
2015
44
0.670
Why?
beta-Alanine
2
2015
11
0.670
Why?
Databases, Factual
5
2021
743
0.670
Why?
Immunologic Factors
1
2019
95
0.670
Why?
Refugees
4
2008
55
0.670
Why?
United States
18
2023
6579
0.660
Why?
Cause of Death
3
2019
164
0.660
Why?
Decision Making
3
2018
340
0.660
Why?
Morpholines
2
2015
65
0.660
Why?
Antibodies, Monoclonal, Humanized
1
2020
178
0.660
Why?
Thiophenes
2
2015
39
0.660
Why?
Patient Participation
1
2020
195
0.650
Why?
Early Detection of Cancer
1
2020
223
0.650
Why?
Statistics as Topic
1
2018
139
0.640
Why?
Benzimidazoles
2
2015
54
0.640
Why?
Amphetamine
1
2017
10
0.630
Why?
Herpes Zoster
1
2017
19
0.620
Why?
Incidence
9
2022
1075
0.610
Why?
Thyroxine
1
2017
51
0.610
Why?
Atherosclerosis
1
2018
125
0.610
Why?
Cerebrovascular Disorders
1
2017
57
0.610
Why?
Guidelines as Topic
4
2012
148
0.610
Why?
Incretins
1
2016
6
0.600
Why?
Antithrombins
1
2017
13
0.600
Why?
Disasters
2
2014
20
0.590
Why?
Lung Neoplasms
2
2020
494
0.580
Why?
Health Services Accessibility
6
2009
472
0.570
Why?
Bronchitis
2
2020
23
0.560
Why?
Arrhythmias, Cardiac
2
2016
97
0.560
Why?
Pharyngitis
2
2006
11
0.550
Why?
Streptococcus pyogenes
2
2006
24
0.550
Why?
Rhabdomyolysis
2
2006
24
0.540
Why?
Fluorobenzenes
2
2005
5
0.530
Why?
Streptococcal Infections
2
2006
68
0.530
Why?
Pharmacoepidemiology
1
2014
12
0.520
Why?
Risk
7
2020
347
0.520
Why?
Vena Cava Filters
2
2014
20
0.520
Why?
Fractures, Bone
3
2011
138
0.520
Why?
Heptanoic Acids
2
2004
17
0.520
Why?
Pyrroles
2
2004
44
0.510
Why?
Aged, 80 and over
12
2021
4285
0.510
Why?
Pyrimidines
2
2005
107
0.510
Why?
Sulfonamides
2
2005
114
0.500
Why?
Tomography, X-Ray Computed
1
2020
1110
0.490
Why?
Developing Countries
4
2008
69
0.490
Why?
Embolism, Paradoxical
1
2014
10
0.490
Why?
Medication Adherence
2
2015
241
0.490
Why?
Bariatric Surgery
3
2013
43
0.480
Why?
Urinary Retention
2
2011
24
0.480
Why?
Azasteroids
1
2013
2
0.480
Why?
5-alpha Reductase Inhibitors
1
2013
2
0.480
Why?
Consensus
3
2018
135
0.480
Why?
Valproic Acid
1
2013
20
0.470
Why?
Health Planning Guidelines
1
2013
28
0.470
Why?
Age Factors
8
2021
1406
0.470
Why?
Relief Work
3
2007
12
0.460
Why?
Dose-Response Relationship, Drug
6
2014
718
0.460
Why?
Meta-Analysis as Topic
5
2015
70
0.450
Why?
Anticonvulsants
1
2013
86
0.450
Why?
Child Development Disorders, Pervasive
1
2013
51
0.450
Why?
Biomedical Research
3
2013
238
0.450
Why?
Prostatic Neoplasms
1
2015
294
0.450
Why?
Insulin
1
2016
653
0.440
Why?
Diagnostic Techniques and Procedures
1
2012
8
0.440
Why?
Cohort Studies
5
2021
2118
0.440
Why?
Epilepsy
1
2013
95
0.430
Why?
Tobacco Use Cessation
1
2012
31
0.430
Why?
Polypharmacy
2
2024
62
0.430
Why?
Pancreatic Neoplasms
1
2015
296
0.430
Why?
Macular Edema
1
2012
18
0.430
Why?
Chronic Disease
6
2021
667
0.430
Why?
Acute Disease
6
2020
603
0.420
Why?
Bupropion
1
2011
8
0.420
Why?
Prenatal Exposure Delayed Effects
1
2013
152
0.420
Why?
Diabetic Angiopathies
2
2008
24
0.410
Why?
Mucociliary Clearance
1
2021
5
0.410
Why?
Reflex
1
2021
24
0.410
Why?
Administration, Oral
5
2023
307
0.400
Why?
Venoms
3
2016
11
0.400
Why?
Wounds and Injuries
1
2014
223
0.400
Why?
Opportunistic Infections
1
2011
27
0.400
Why?
Dipeptidyl-Peptidase IV Inhibitors
4
2021
9
0.400
Why?
Autistic Disorder
1
2013
155
0.400
Why?
Quality of Life
3
2020
806
0.390
Why?
Nicotine
1
2011
101
0.390
Why?
Retrospective Studies
10
2023
4901
0.390
Why?
Respiratory Tract Infections
1
2011
69
0.380
Why?
Lower Extremity
3
2021
121
0.380
Why?
Product Surveillance, Postmarketing
4
2012
18
0.380
Why?
Anti-Inflammatory Agents, Non-Steroidal
2
2011
168
0.380
Why?
Bronchitis, Chronic
1
2020
5
0.380
Why?
Child
11
2020
3910
0.370
Why?
Eosinophilia
1
2020
24
0.370
Why?
Suicide
1
2011
108
0.370
Why?
Postoperative Complications
4
2013
930
0.360
Why?
Outpatients
2
2020
122
0.360
Why?
Mortality
3
2018
140
0.360
Why?
Kidney Failure, Chronic
2
2008
164
0.360
Why?
International Cooperation
5
2008
80
0.350
Why?
Glucagon-Like Peptide-1 Receptor
2
2021
13
0.350
Why?
Observational Studies as Topic
3
2019
43
0.350
Why?
Diphosphonates
1
2009
31
0.340
Why?
Depression
3
2014
793
0.340
Why?
Outsourced Services
1
2008
3
0.340
Why?
Health
2
2006
32
0.340
Why?
Whooping Cough
1
2018
15
0.340
Why?
Gastroesophageal Reflux
1
2019
65
0.340
Why?
Polyethylene Glycols
2
2023
162
0.340
Why?
Bone Density Conservation Agents
1
2009
47
0.340
Why?
Publication Bias
4
2012
19
0.340
Why?
Pregnancy Complications
1
2013
374
0.330
Why?
Emigration and Immigration
2
2008
22
0.330
Why?
Bronchiolitis, Viral
1
2018
4
0.330
Why?
Disaster Planning
3
2015
34
0.330
Why?
Adolescent
9
2020
5300
0.330
Why?
Patient Education as Topic
2
2011
429
0.330
Why?
Hemorrhage
3
2023
235
0.320
Why?
Stomatitis
1
2008
4
0.320
Why?
Lung Diseases, Interstitial
1
2018
38
0.320
Why?
Simvastatin
2
2005
27
0.320
Why?
Attitude to Health
2
2008
277
0.320
Why?
Antiviral Agents
2
2023
303
0.320
Why?
Secondary Prevention
2
2019
132
0.320
Why?
Interferon-alpha
1
2008
93
0.310
Why?
Patient Advocacy
1
2007
23
0.310
Why?
Peptides
3
2016
509
0.310
Why?
Civil Disorders
1
2007
2
0.310
Why?
Young Adult
7
2021
3731
0.310
Why?
Contrast Media
2
2008
300
0.300
Why?
Lisinopril
1
2006
4
0.300
Why?
Child Welfare
2
2009
48
0.300
Why?
Critical Illness
1
2020
291
0.300
Why?
Mass Screening
2
2017
558
0.300
Why?
Renal Dialysis
1
2008
169
0.290
Why?
Sample Size
4
2023
49
0.290
Why?
Tuberculosis, Pulmonary
1
2017
93
0.290
Why?
Amiodarone
1
2006
12
0.290
Why?
Clinical Clerkship
1
2006
77
0.280
Why?
Information Dissemination
1
2007
111
0.280
Why?
Smoking Cessation
1
2011
498
0.280
Why?
Pulmonary Alveoli
1
2006
44
0.280
Why?
Hydralazine
1
2006
1
0.280
Why?
Influenza, Human
1
2018
183
0.280
Why?
Anti-Arrhythmia Agents
1
2006
29
0.280
Why?
Self Care
1
2008
209
0.280
Why?
Angiotensin-Converting Enzyme Inhibitors
1
2006
137
0.280
Why?
Vasodilator Agents
1
2006
48
0.280
Why?
Vasoconstrictor Agents
1
2006
49
0.270
Why?
Patient Selection
5
2015
352
0.270
Why?
Internal Medicine
1
2006
137
0.270
Why?
Religion and Medicine
1
2005
21
0.270
Why?
Myelography
1
2005
1
0.270
Why?
Cocaine-Related Disorders
1
2006
62
0.270
Why?
Iopamidol
1
2005
13
0.270
Why?
Religion
1
2005
27
0.270
Why?
Carotid Stenosis
1
2006
86
0.270
Why?
Aging
1
2021
687
0.270
Why?
Bariatrics
1
2005
1
0.270
Why?
Cocaine
1
2006
82
0.260
Why?
Aminopyridines
2
2016
21
0.260
Why?
Pharynx
1
2005
20
0.260
Why?
Benzamides
2
2016
48
0.260
Why?
Disease Outbreaks
1
2005
99
0.260
Why?
Formularies as Topic
1
2004
2
0.260
Why?
Follow-Up Studies
4
2018
1925
0.260
Why?
Patient-Centered Care
2
2019
225
0.260
Why?
Community Health Services
1
2006
128
0.260
Why?
Societies, Medical
1
2006
238
0.260
Why?
Peripheral Nervous System Diseases
1
2005
30
0.260
Why?
Lung Diseases
1
2006
135
0.260
Why?
Referral and Consultation
1
2008
359
0.260
Why?
Lupus Erythematosus, Systemic
1
2006
131
0.260
Why?
Healthcare Disparities
1
2008
280
0.250
Why?
Acute Kidney Injury
1
2006
94
0.250
Why?
Seizures
1
2005
94
0.250
Why?
Social Justice
1
2004
30
0.250
Why?
Antipsychotic Agents
2
2015
284
0.250
Why?
Kidney Transplantation
1
2006
242
0.250
Why?
Drug Therapy, Combination
5
2018
355
0.250
Why?
Potentially Inappropriate Medication List
1
2024
13
0.250
Why?
Drug Administration Schedule
3
2014
245
0.240
Why?
Bias
3
2014
98
0.240
Why?
Health Services
1
2004
86
0.240
Why?
Obesity
2
2013
1137
0.240
Why?
Heart Transplantation
1
2004
104
0.240
Why?
Health Knowledge, Attitudes, Practice
2
2009
697
0.240
Why?
Tenofovir
1
2023
8
0.240
Why?
Inappropriate Prescribing
1
2024
54
0.230
Why?
Intracranial Aneurysm
1
2006
203
0.230
Why?
Socioeconomic Factors
5
2016
754
0.230
Why?
Adenine
1
2023
36
0.230
Why?
Child Abuse
1
2004
80
0.230
Why?
Military Personnel
1
2004
84
0.230
Why?
Rivaroxaban
3
2023
18
0.230
Why?
Physicians
3
2022
412
0.230
Why?
Blood Glucose
3
2018
460
0.220
Why?
Health Expenditures
1
2004
97
0.220
Why?
Dementia
1
2005
200
0.220
Why?
Acquired Immunodeficiency Syndrome
3
2009
129
0.220
Why?
Ivermectin
1
2022
7
0.220
Why?
Reproducibility of Results
3
2017
1329
0.220
Why?
Kidney
2
2023
348
0.220
Why?
Influenza Vaccines
1
2023
83
0.210
Why?
Caregivers
1
2024
176
0.210
Why?
Hypertension
1
2007
544
0.210
Why?
Varenicline
2
2011
9
0.210
Why?
Double-Blind Method
3
2023
533
0.210
Why?
Pilot Projects
3
2017
787
0.210
Why?
International Classification of Diseases
2
2019
134
0.200
Why?
Venous Thromboembolism
2
2013
152
0.200
Why?
Delphi Technique
3
2019
69
0.200
Why?
Medication Systems
1
2021
18
0.200
Why?
Diuretics
1
2021
52
0.200
Why?
Calcium Channel Blockers
1
2021
48
0.200
Why?
Data Collection
2
2019
365
0.200
Why?
Severity of Illness Index
2
2020
1187
0.200
Why?
Pharmacy
1
2021
14
0.200
Why?
Ambulatory Care
3
2023
260
0.200
Why?
Case-Control Studies
3
2013
942
0.190
Why?
Proton Pump Inhibitors
2
2019
31
0.190
Why?
Anti-Infective Agents
1
2022
116
0.190
Why?
Peripheral Arterial Disease
2
2020
126
0.190
Why?
Medication Errors
1
2021
117
0.190
Why?
Safety Management
2
2012
141
0.190
Why?
Vaccination
4
2023
293
0.190
Why?
Vaccines
1
2021
91
0.190
Why?
Prevalence
5
2013
1108
0.190
Why?
Drug Labeling
2
2012
28
0.190
Why?
Prognosis
3
2014
1262
0.180
Why?
Pharmacists
1
2021
115
0.180
Why?
Death Certificates
1
2019
8
0.180
Why?
Electronic Health Records
2
2019
314
0.180
Why?
Patient Safety
2
2012
216
0.180
Why?
Vulnerable Populations
2
2013
77
0.180
Why?
Medicare
1
2023
513
0.180
Why?
Monoclonal Gammopathy of Undetermined Significance
1
2019
32
0.170
Why?
Canagliflozin
1
2018
2
0.170
Why?
Reminder Systems
1
2019
72
0.170
Why?
Health Status
2
2016
396
0.170
Why?
Armed Conflicts
1
2018
2
0.170
Why?
Exposure to Violence
1
2018
4
0.170
Why?
Data Interpretation, Statistical
3
2015
185
0.160
Why?
Health Facilities
1
2018
35
0.160
Why?
Comparative Effectiveness Research
3
2013
37
0.160
Why?
Education
1
2018
70
0.160
Why?
Quality Control
1
2018
63
0.160
Why?
Multiple Chronic Conditions
1
2018
33
0.160
Why?
Osteoporotic Fractures
1
2018
34
0.160
Why?
Budesonide
2
2023
10
0.160
Why?
Health Education
1
2019
182
0.160
Why?
Cooperative Behavior
1
2019
208
0.160
Why?
Respiratory Function Tests
2
2009
110
0.160
Why?
Communication
2
2019
477
0.160
Why?
Herpes Zoster Ophthalmicus
1
2017
6
0.160
Why?
Torture
2
2008
2
0.160
Why?
Metformin
2
2015
64
0.160
Why?
Crime Victims
1
2018
40
0.160
Why?
Stress, Psychological
2
2014
385
0.150
Why?
Population Surveillance
1
2018
197
0.150
Why?
Practice Patterns, Physicians'
2
2021
695
0.150
Why?
Insulin Detemir
1
2016
1
0.150
Why?
Glucagon-Like Peptides
1
2016
1
0.150
Why?
Insulin Glargine
1
2016
2
0.150
Why?
Insulin, Long-Acting
1
2016
2
0.150
Why?
Liraglutide
1
2016
4
0.150
Why?
Observer Variation
1
2017
175
0.150
Why?
Cross-Sectional Studies
3
2019
2204
0.150
Why?
Medical Records
1
2017
125
0.150
Why?
China
2
2008
99
0.150
Why?
Hormone Replacement Therapy
1
2016
32
0.150
Why?
Thiamine Deficiency
2
2007
5
0.140
Why?
Androgens
1
2016
53
0.140
Why?
Immunoglobulin Fc Fragments
1
2016
46
0.140
Why?
Antiretroviral Therapy, Highly Active
2
2006
95
0.140
Why?
Registries
1
2019
702
0.140
Why?
Drug Evaluation
1
2016
18
0.140
Why?
Widowhood
1
2016
3
0.140
Why?
Surge Capacity
1
2015
2
0.140
Why?
Social Isolation
1
2016
23
0.140
Why?
Hypoglycemia
1
2016
67
0.140
Why?
Drug Interactions
2
2007
103
0.140
Why?
Research
2
2015
184
0.140
Why?
Sensitivity and Specificity
3
2014
954
0.140
Why?
Insurance Claim Review
1
2015
73
0.140
Why?
Hospital Mortality
1
2020
779
0.140
Why?
Cognitive Dysfunction
1
2018
208
0.140
Why?
Checklist
1
2016
63
0.130
Why?
Rosuvastatin Calcium
2
2005
3
0.130
Why?
Comorbidity
1
2018
995
0.130
Why?
Altruism
1
2014
12
0.130
Why?
Adrenomedullin
1
2014
1
0.130
Why?
Recombinant Fusion Proteins
1
2016
456
0.130
Why?
Violence
2
2007
155
0.130
Why?
Multiple Myeloma
1
2019
281
0.130
Why?
Publishing
1
2016
86
0.130
Why?
Protein Precursors
1
2014
66
0.130
Why?
Aspirin
1
2015
165
0.120
Why?
Health Services Needs and Demand
2
2007
201
0.120
Why?
Phosphodiesterase 4 Inhibitors
1
2013
2
0.120
Why?
Health Services Research
1
2015
264
0.120
Why?
Patient Compliance
2
2006
324
0.120
Why?
Bibliometrics
1
2013
25
0.120
Why?
Time Factors
3
2011
3164
0.120
Why?
Dutasteride
1
2013
1
0.120
Why?
Pakistan
1
2013
7
0.120
Why?
Prostatic Diseases
1
2013
6
0.120
Why?
Sex Workers
1
2013
5
0.120
Why?
Publications
1
2013
25
0.120
Why?
Sitagliptin Phosphate
1
2013
2
0.120
Why?
Emergency Medicine
1
2015
158
0.120
Why?
Diabetes Mellitus
1
2018
504
0.120
Why?
Meditation
1
2014
55
0.120
Why?
Bone Density
2
2018
165
0.120
Why?
Prospective Studies
2
2017
2637
0.120
Why?
Tetrabenazine
1
2013
1
0.120
Why?
Affect
1
2014
116
0.120
Why?
Adrenergic Uptake Inhibitors
1
2013
13
0.110
Why?
Drug Recalls
1
2012
1
0.110
Why?
Social Support
1
2016
340
0.110
Why?
Triazoles
1
2013
54
0.110
Why?
Pyrazines
1
2013
31
0.110
Why?
Substance Abuse, Intravenous
1
2013
61
0.110
Why?
Therapeutic Equivalency
1
2012
9
0.110
Why?
Endpoint Determination
1
2012
22
0.110
Why?
Risk Reduction Behavior
1
2013
123
0.110
Why?
Histamine H2 Antagonists
1
2012
8
0.110
Why?
Bayes Theorem
2
2023
98
0.110
Why?
Neoplasms
2
2015
1092
0.110
Why?
Enterocolitis, Pseudomembranous
1
2012
29
0.110
Why?
Emergency Service, Hospital
1
2019
864
0.110
Why?
MP3-Player
1
2011
2
0.100
Why?
Suicidal Ideation
1
2013
100
0.100
Why?
Androstadienes
1
2011
14
0.100
Why?
Fluticasone
1
2011
5
0.100
Why?
Platelet Aggregation Inhibitors
1
2013
198
0.100
Why?
Huntington Disease
1
2013
130
0.100
Why?
Neuromuscular Diseases
1
2021
17
0.100
Why?
Survival Analysis
1
2012
471
0.100
Why?
Health Care Rationing
2
2015
20
0.100
Why?
Mental Disorders
2
2009
686
0.100
Why?
Salmeterol Xinafoate
1
2010
2
0.100
Why?
Observation
1
2010
24
0.100
Why?
Albuterol
1
2010
16
0.100
Why?
Reference Values
1
2011
296
0.100
Why?
Patient Satisfaction
2
2011
371
0.100
Why?
Symptom Flare Up
1
2020
11
0.090
Why?
Biomechanical Phenomena
1
2021
229
0.090
Why?
Symptom Assessment
1
2020
38
0.090
Why?
Needs Assessment
2
2015
163
0.090
Why?
Technology, Pharmaceutical
1
2009
18
0.090
Why?
Quality Indicators, Health Care
1
2012
327
0.090
Why?
Respiratory Aspiration
1
2009
4
0.090
Why?
Logistic Models
1
2013
1173
0.090
Why?
Anti-Retroviral Agents
1
2009
71
0.090
Why?
Program Evaluation
2
2011
461
0.090
Why?
Sodium Bicarbonate
1
2008
11
0.090
Why?
Bronchoscopy
1
2009
53
0.090
Why?
Latin America
1
2008
13
0.090
Why?
Africa
1
2008
16
0.090
Why?
Foreign Bodies
1
2009
39
0.090
Why?
Japan
1
2008
49
0.090
Why?
Russia
1
2008
48
0.090
Why?
Drug Discovery
1
2009
79
0.090
Why?
Taiwan
2
2021
6
0.080
Why?
Sarcoidosis, Pulmonary
1
2018
7
0.080
Why?
Colorectal Neoplasms
1
2011
225
0.080
Why?
Scleroderma, Systemic
1
2018
13
0.080
Why?
Thiamine
2
2007
19
0.080
Why?
Tibet
2
2006
3
0.080
Why?
Government Regulation
1
2008
41
0.080
Why?
Sex Factors
1
2021
840
0.080
Why?
Research Support as Topic
1
2008
42
0.080
Why?
Drug Industry
1
2008
40
0.080
Why?
Recurrence
2
2012
493
0.080
Why?
Odds Ratio
2
2008
764
0.080
Why?
India
1
2008
142
0.080
Why?
Kidney Function Tests
1
2008
32
0.080
Why?
Anti-HIV Agents
2
2006
142
0.080
Why?
Nephrology
1
2008
15
0.080
Why?
Sulfonylurea Compounds
2
2020
13
0.080
Why?
Health Personnel
2
2018
325
0.080
Why?
Cardiac Output, Low
1
2007
8
0.080
Why?
Causality
1
2008
55
0.080
Why?
Postgastrectomy Syndromes
1
2007
3
0.080
Why?
Rwanda
1
2007
11
0.080
Why?
Malabsorption Syndromes
1
2007
4
0.080
Why?
Anecdotes as Topic
1
2007
11
0.080
Why?
Osteoporosis
1
2009
128
0.080
Why?
Toxins, Biological
1
2007
6
0.080
Why?
Public Policy
1
2008
31
0.080
Why?
Child, Preschool
2
2020
1698
0.080
Why?
Homicide
1
2007
21
0.080
Why?
Homosexuality, Male
1
2007
22
0.080
Why?
New York City
1
2007
71
0.080
Why?
Patient Care Planning
1
2008
77
0.080
Why?
Catheters, Indwelling
1
2008
61
0.080
Why?
Health Policy
2
2008
162
0.080
Why?
Kidney Diseases
1
2008
145
0.080
Why?
Anxiety
2
2014
360
0.080
Why?
Internet
1
2011
465
0.080
Why?
Communicable Disease Control
1
2007
36
0.080
Why?
Catheterization, Central Venous
1
2008
79
0.070
Why?
Theft
1
2006
3
0.070
Why?
Biomarkers
2
2014
1022
0.070
Why?
Developed Countries
1
2006
11
0.070
Why?
Disease Susceptibility
1
2007
136
0.070
Why?
Safety
1
2007
125
0.070
Why?
Communicable Diseases
1
2007
72
0.070
Why?
History, 21st Century
1
2007
139
0.070
Why?
Educational Status
1
2008
263
0.070
Why?
Minority Groups
1
2008
126
0.070
Why?
Vascular Neoplasms
1
2006
12
0.070
Why?
HIV
1
2006
67
0.070
Why?
Police
1
2006
32
0.070
Why?
Infant Mortality
1
2006
19
0.070
Why?
Expert Systems
1
2006
5
0.070
Why?
Guideline Adherence
1
2008
272
0.070
Why?
Life Change Events
1
2006
63
0.070
Why?
History, 20th Century
1
2007
220
0.070
Why?
Penicillins
1
2006
24
0.070
Why?
Vasoconstriction
1
2006
14
0.070
Why?
Likelihood Functions
1
2006
69
0.070
Why?
Pregnancy
1
2013
2197
0.070
Why?
Ethics, Research
1
2006
19
0.070
Why?
Lymphoma, Large B-Cell, Diffuse
1
2006
53
0.070
Why?
Endarterectomy, Carotid
1
2006
74
0.070
Why?
Thrombosis
1
2008
171
0.070
Why?
Tachycardia, Ventricular
1
2006
43
0.070
Why?
AIDS Vaccines
1
2006
62
0.070
Why?
Recombinant Proteins
1
2008
642
0.070
Why?
Condoms
1
2005
38
0.070
Why?
Child Health Services
1
2006
59
0.070
Why?
Maternal Health Services
1
2006
58
0.070
Why?
Decision Support Systems, Clinical
1
2006
65
0.070
Why?
Patient Care Team
1
2008
285
0.070
Why?
Educational Measurement
1
2006
188
0.070
Why?
Diabetic Nephropathies
1
2005
34
0.070
Why?
Horner Syndrome
1
2005
1
0.070
Why?
Communism
1
2004
1
0.070
Why?
Carotid Artery, Internal, Dissection
1
2005
6
0.070
Why?
War Crimes
1
2004
2
0.070
Why?
Nutrition Disorders
1
2004
7
0.070
Why?
Principle-Based Ethics
1
2004
2
0.070
Why?
Cyclopropanes
2
2016
34
0.070
Why?
Infant
2
2006
1423
0.070
Why?
Poverty
1
2007
281
0.060
Why?
Psychology, Child
1
2004
6
0.060
Why?
Family Practice
1
2006
180
0.060
Why?
Resource Allocation
1
2004
19
0.060
Why?
Rural Health
1
2004
16
0.060
Why?
Health Planning
1
2004
24
0.060
Why?
Malaria, Vivax
1
2005
32
0.060
Why?
Cyclosporine
1
2004
52
0.060
Why?
Total Quality Management
1
2004
50
0.060
Why?
Education, Medical
1
2006
164
0.060
Why?
Child Advocacy
1
2004
6
0.060
Why?
Massachusetts
2
2021
1979
0.060
Why?
Drug Utilization
1
2006
216
0.060
Why?
Drug Delivery Systems
1
2008
271
0.060
Why?
Embolization, Therapeutic
1
2006
172
0.060
Why?
Morbidity
1
2004
91
0.060
Why?
Postoperative Care
1
2004
95
0.060
Why?
Medicaid
2
2019
308
0.060
Why?
Gastric Bypass
1
2004
71
0.060
Why?
Africa South of the Sahara
3
2009
16
0.060
Why?
Pyridones
1
2023
27
0.060
Why?
Factor Xa Inhibitors
1
2023
32
0.060
Why?
Pragmatic Clinical Trials as Topic
1
2023
4
0.060
Why?
Students, Medical
1
2006
218
0.060
Why?
Fluvoxamine
1
2023
1
0.060
Why?
Diagnosis, Differential
1
2006
740
0.060
Why?
Stents
1
2006
328
0.060
Why?
Injections, Subcutaneous
1
2023
69
0.060
Why?
Curriculum
1
2006
508
0.060
Why?
Immunosuppressive Agents
1
2004
261
0.060
Why?
National Institutes of Health (U.S.)
1
2023
92
0.060
Why?
Antineoplastic Agents
1
2008
534
0.060
Why?
United States Agency for Healthcare Research and Quality
2
2012
29
0.060
Why?
Intention
1
2022
59
0.050
Why?
Infant, Newborn
1
2006
1216
0.050
Why?
Peripheral Vascular Diseases
1
2021
42
0.050
Why?
Glucosides
1
2020
9
0.050
Why?
Liver
1
2005
715
0.050
Why?
Interviews as Topic
2
2016
420
0.050
Why?
Benzhydryl Compounds
1
2020
35
0.050
Why?
Clinical Competence
1
2004
598
0.050
Why?
Tennessee
1
2019
13
0.050
Why?
Administrative Claims, Healthcare
1
2019
10
0.050
Why?
Longitudinal Studies
1
2023
1056
0.050
Why?
Qualitative Research
2
2016
455
0.040
Why?
Clinical Coding
1
2019
39
0.040
Why?
United Nations
2
2009
4
0.040
Why?
Government
1
2018
8
0.040
Why?
Bombs
1
2018
3
0.040
Why?
Syria
1
2018
11
0.040
Why?
Epidemiological Monitoring
1
2018
24
0.040
Why?
Propensity Score
1
2018
110
0.040
Why?
Mass Casualty Incidents
1
2018
24
0.040
Why?
Surveys and Questionnaires
2
2018
2301
0.040
Why?
Health Resources
1
2018
72
0.040
Why?
Predictive Value of Tests
1
2019
830
0.040
Why?
Disease Progression
1
2019
765
0.040
Why?
Consensus Development Conferences as Topic
1
2015
16
0.030
Why?
Quetiapine Fumarate
1
2015
12
0.030
Why?
Cyclohexanecarboxylic Acids
1
2015
11
0.030
Why?
Heparin
2
2008
92
0.030
Why?
Selection Bias
1
2015
25
0.030
Why?
Neuralgia
1
2015
17
0.030
Why?
Amines
1
2015
29
0.030
Why?
gamma-Aminobutyric Acid
1
2015
73
0.030
Why?
Analgesics
1
2015
89
0.030
Why?
Triage
1
2015
95
0.030
Why?
Adaptation, Psychological
1
2016
236
0.030
Why?
Placebos
1
2013
70
0.030
Why?
Community-Acquired Infections
1
2014
85
0.030
Why?
Proportional Hazards Models
1
2015
596
0.030
Why?
Heparin, Low-Molecular-Weight
1
2013
25
0.030
Why?
Emotions
1
2016
198
0.030
Why?
Enoxaparin
1
2013
18
0.030
Why?
Nasal Sprays
1
2012
2
0.030
Why?
Nebulizers and Vaporizers
1
2012
23
0.030
Why?
Bipolar Disorder
1
2015
238
0.030
Why?
Computer Graphics
1
2012
23
0.030
Why?
Critical Care
1
2015
357
0.030
Why?
International Normalized Ratio
1
2011
34
0.030
Why?
North Carolina
1
2011
43
0.030
Why?
Pulmonary Embolism
1
2013
149
0.030
Why?
Terminology as Topic
1
2012
116
0.030
Why?
Computer-Assisted Instruction
1
2011
71
0.020
Why?
Patient Preference
1
2011
69
0.020
Why?
Health Literacy
1
2011
74
0.020
Why?
Voluntary Health Agencies
1
2009
4
0.020
Why?
Rape
1
2009
13
0.020
Why?
Body Weight
1
2011
379
0.020
Why?
Sodium Chloride
1
2008
50
0.020
Why?
Age Distribution
1
2009
232
0.020
Why?
Lipids
1
2011
284
0.020
Why?
Sexual Behavior
1
2009
170
0.020
Why?
Infusions, Intravenous
1
2008
153
0.020
Why?
Bhutan
1
2008
20
0.020
Why?
Animals
1
2006
18043
0.020
Why?
Elephantiasis, Filarial
1
2007
9
0.020
Why?
Myanmar
1
2007
9
0.020
Why?
Yellow Fever
1
2007
3
0.020
Why?
Colombia
1
2007
14
0.020
Why?
Leishmaniasis, Cutaneous
1
2007
12
0.020
Why?
Half-Life
1
2007
64
0.020
Why?
Chagas Disease
1
2007
31
0.020
Why?
Thrombocytopenia
1
2008
46
0.020
Why?
Hunger
1
2006
15
0.020
Why?
Social Welfare
1
2006
19
0.020
Why?
Time
1
2006
26
0.020
Why?
Leukocyte Common Antigens
1
2006
46
0.020
Why?
North America
1
2006
109
0.020
Why?
Coercion
1
2006
39
0.020
Why?
Fatal Outcome
1
2006
102
0.020
Why?
Lymphoma, B-Cell
1
2006
50
0.020
Why?
Multiple Organ Failure
1
2006
39
0.020
Why?
Clinical Trials Data Monitoring Committees
1
2006
5
0.020
Why?
Cambodia
1
2005
18
0.020
Why?
Confidentiality
1
2006
54
0.020
Why?
Primary Health Care
1
2011
574
0.020
Why?
Self-Help Groups
1
2005
39
0.020
Why?
Prisons
1
2006
91
0.020
Why?
Attitude
1
2006
90
0.020
Why?
Quinine
1
2005
3
0.020
Why?
Informed Consent
1
2006
109
0.020
Why?
Doxycycline
1
2005
35
0.020
Why?
Chloroquine
1
2005
49
0.020
Why?
Drug Resistance, Microbial
1
2005
39
0.020
Why?
Antimalarials
1
2005
65
0.020
Why?
Erythrocytes
1
2005
143
0.020
Why?
Stress Disorders, Post-Traumatic
1
2008
339
0.010
Why?
Singh's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (655)
Explore
_
Co-Authors (27)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_